entertainment -WSS

entertainment

author：explore 2025-10-02 18:48:44 - browse：9244

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： NYC plans to house migrants on an island in the East River

WSS

Pfizer highlights cancer drugs it thinks could reignite investor interest

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Scientists unlock the key to scar

Obesity now affects over 1 billion people worldwide, study finds

Change Healthcare cyberattack outage could last weeks

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

hotspot

entertainment

explore

ChatGPT in medicine: STAT answers readers' burning questions

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Novavax promises a turnaround & Lilly roils the obesity market

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

State Dept. review finds Biden bears some blame for Afghanistan failures

RSV vaccines may be linked to small increased risk of developing GBS

State Dept. review finds Biden bears some blame for Afghanistan failures

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mississippi candidates for statewide offices square off in party primaries

leisure time

ALS groups 'won't be played again' by the FDA, drug sponsors

A Q&A with Aletha Maybank, AMA’s chief health equity officer

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

How to fix the rural physician shortage in the U.S.

Biotech companies concerned about China biosecurity crackdown

leisure time

Wikipedia

explore

knowledge